Over the past 10 years, large molecule therapies have increased from 10% to nearly 50% of the typical pharma and biopharmaceutical pipeline. This transition has created new challenges in the industry.
To address these challenges and boost productivity, QPS has teamed up with SCIEX, a global leader in life science analytical technologies, to advance a hybrid LBA – LCMS workflow for routine biologics quantification. QPS will be deploying the SCIEX BioBA Solution, the first end-to-end and most complete solution for bioanalysis of biologics. SCIEX developed this system to optimize robust, reproducible and sensitive quantification methods for proteins. For QPS, the system’s simplicity, standardization and efficiency should help in finding that right answer faster when it comes to large molecule bioanalysis.
The comprehensive BioBA solution includes sample preparation kits, automated liquid sample handling, an LC component, and a QTRAP® MS System with software for performing bioanalytical studies designed to support CFR 21 part 11 compliance. It also comes with SCIEX’s world-class support.
Please see Press Release here:
Find out more about Bioanalysis at QPS.